Clinical Trial Update: Efficacy and Safety of BBT-401-1S in Ulcerative Colitis [Phase 2]

View source ↗

Summary

Phase 2 trial of BBT-401-1S in ulcerative colitis was terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• BBT-401-1S

Snippet

Sponsor: Bridge Biotherapeutics, Inc. | Conditions: Ulcerative Colitis | Phase 2 | Status: TERMINATED | Results posted: 2022-03-21